Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by TheeRookon Jan 03, 2022 3:13pm
242 Views
Post# 34279895

RE:Hurry up THRM

RE:Hurry up THRMLots of company are late to the party.   Jun 05, 2020,
U can preorder one of these.


Metabolic Insights Inc. (Metabolic Insights) is pleased to announce that it has been awarded a $300,000 grant by the Industrial Research Assistance Program of the National Research Council through their competitive Innovative Solutions Canada Challenge Program. The funds will be used to re-purpose the Company's existing proprietary salivary insulin technology to detect the SARS-2-CoV (COVID-19) virus in saliva. One of the objectives of the challenge is to demonstrate a new prototype point-of-care COVID-19 test in three months.

https://www.prnewswire.com/news-releases/metabolic-insights-inc-awarded-300-000-by-nrc-irap-to-develop-a-prototype-point-of-care-covid-19-virus-test-301071611.html



13X2413 wrote: Rapid tests getting more and more support. Let's get these to market, fast!!

“I think the confusion is that rapid antigen tests have never been as sensitive as the PCR test,” Fauci said. “They're very good when they are given sequentially. So if you do them like maybe two or three times over a few-day period, at the end of the day, they are as good as the PCR. But as a single test, they are not as sensitive.”
 


<< Previous
Bullboard Posts
Next >>